In the present study, NECL-5 expression was observed at different levels in tissue samples from normal skin, benign melanocytic nevi and primary and metastatic melanoma suggesting that NECL-5 may be a potential marker of melanoma progression. This evidence concerns the gene PVR and metastatic melanoma.